The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Philippines seals biggest COVID-19 vaccine order yet, for 40 mln Pfizer doses

Sun, 20th Jun 2021 16:45

* Deliveries to begin in late September

* Philippines has secured 113 mln doses from vaccine
suppliers

* Government wants to vaccinate up to 70 million Filipinos
(Updates with Israel medical experts arriving to help boost
vaccine rollout)

MANILA, June 20 (Reuters) - The Philippine government has
signed a supply agreement for 40 million doses of the COVID-19
vaccine developed by Pfizer Inc and BioNTech SE,
in its biggest coronavirus vaccine deal to date.

Deliveries of the vaccine will begin in late September,
Carlito Galvez, head of the government's COVID-19 vaccine
procurement, said on Sunday. It "will significantly boost our
national immunisation programme and will enable us to realise
our goal of achieving herd immunity by year-end," he said.

The Philippines has now ordered 113 million doses from five
vaccine manufacturers, including 26 million from China's Sinovac
, 10 million of Russia's Sputnik V, 20 million doses from
Moderna and 17 million doses from AstraZeneca.

So far, the Philippines has adminstered slightly more than 8
million doses, of which about 6 million were first doses, making
slow progress towards the government's target to vaccinate up to
70 million people this year in a country of 110 million.

The Philippines earlier this month started a programme to
vaccinate 35 million people working outside their homes, while
continuing to inoculate priority sectors such as healthcare
workers and the elderly.

Vaccine supply around the capital Manila remains limited,
while COVID-19 cases in several provinces have surged,
complicating efforts to ramp up the immunisation drive in a
country with some of Asia's largest numbers of infections and
deaths.

The Philippines also expects 44 million doses from the
international COVAX vaccine sharing facility. Orders of 16
million doses of vaccines developed by Novavax and
Johnson & Johnson were still under negotiation, Galvez
said.

The Philippines will allow the Pfizer-BioNTech vaccine to be
given to children aged 12 to 15, possibly starting later this
year, he said.

To help boost the government's COVID-19 response, a team of
medical experts from the Israel Ministry of Health has arrived
in Manila. Israel has been a world leader in rolling out
vaccines, having successfully reduced its active COVID-19 cases
and gradually reopened its economy. Most of its population has
received the Pfizer-BioNTech vaccine.

Galvez said the health experts will share strategies,
including how to address vaccine hesitancy.
(Reporting by Enrico Dela Cruz; Editing by William Mallard and
Christopher Cushing)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.